Markels John
SEC insider (Form 3/4/5 filer). CIK 0001803424. Director at Vaxcyte, Inc. (PCVX) and 2 other issuers. 4 reported Form 4/5 transactions since Sep 2024; latest on Jul 16, 2026. Located in SAN CARLOS, CA.
Companies Markels John has filed insider reports for
- Vaxcyte, Inc. (PCVX): Director
- Arcturus Therapeutics Holdings Inc. (ARCT): Director
- SANGAMO THERAPEUTICS, INC (SGMO): Director
Markels John
CIK: 0001803424
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 16, 2026PCVX
Vaxcyte, Inc.
AwardDirectStock Option (right to buy)
23K shares- - Jun 5, 2026ARCT
Arcturus Therapeutics Holdings Inc.
AwardDirectStock option (right to buy)
15K shares- - Jun 12, 2025SGMO
SANGAMO THERAPEUTICS, INC
AwardDirect25K shares- - Jun 9, 2025ARCT
Arcturus Therapeutics Holdings Inc.
AwardDirectStock option (right to buy)
15K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 16, 2026 |  PCVX Vaxcyte, Inc. | Award Stock Option (right to buy) | 23,029 | - | - | Direct |
| Jun 5, 2026 |  ARCT Arcturus Therapeutics Holdings Inc. | Award Stock option (right to buy) | 15,000 | - | - | Direct |
| Jun 12, 2025 |  SGMO SANGAMO THERAPEUTICS, INC | Award | 25,000 | - | - | Direct |
| Jun 9, 2025 | ARCT Arcturus Therapeutics Holdings Inc. | Award Stock option (right to buy) | 15,000 | - | - | Direct |
1-4 of 4 transactions